Finally, although we focused on the presence of circulating degranulated and activated platelets, we acknowledge that many other contributors (eg, endothelial dysfunction, von Willebrand factor activity, thrombin generation) play a role in the onset of thrombotic and bleeding complications in patients with COVID-19. This evidence concerns the gene VWF and COVID-19.